Heart Failure with Preserved Ejection Fraction Program

At NYU Langone’s Heart Failure with Preserved Ejection Fraction (HFpEF) Program, our team offers comprehensive diagnosis and therapies for the management of this condition, with the aim to improve symptoms and quality of life and reduce the risk of hospitalization.

Understanding Heart Failure with Preserved Ejection Fraction

Of the 6.7 million annual cases of heart failure that occur in the United States, HFpEF accounts for nearly half. By 2030, these cases are expected to go up to 8.3 million. People with HFpEF are at high risk of being hospitalized both for cardiac and non-cardiac causes. The prevalence of HFpEF is higher in women than in men, and risk increases with age.

When we talk about heart failure, we often refer to ejection fraction. This is a measure of how well your heart is pumping blood to the rest of your body. In the case of HFpEF, the ejection fraction is normal, which means the heart is pumping as it should. However, the heart muscle becomes thicker and stiffer, making it hard for the heart to relax.

HFpEF may present with the following symptoms:

• abdominal swelling
• exercise intolerance
• fatigue
• shortness of breath, while upright or lying flat
• swelling in the lower extremities

Our Comprehensive Approach

As part of NYU Langone’s Heart Failure Advanced Care Center, we provide comprehensive, evidence-based care for people with HFpEF. Our approach focuses on improving your symptoms, enhancing your quality of life, and minimizing the need for hospital visits.

To ensure you receive the most individualized and effective care, our diverse team of experts includes pulmonologists, pulmonary hypertension specialists, weight management experts, endocrinologists, nephrologists, and cardiology subspecialists including electrophysiologists and interventional cardiologists.

We also offer a dedicated program that helps people with HFpEF participate in ongoing clinical trials and research studies for novel treatments and devices.